CLG LLC
ABBV icon

CLG LLC’s AbbVie ABBV Stock Holding History

CLG LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$421K Sell
1,610
-1,361
-46% -$349K 0.09% 99
2026
Q2 		$748K Buy
2,971
+11
+0.4% +$2.37K 0.16% 74
2026
Q1 		$644K Buy
2,960
+10
+0.3% +$2.22K 0.16% 75
2025
Q4 		$674K Sell
2,950
-11
-0.4% -$2.51K 0.17% 69
2025
Q3 		$686K Buy
2,961
+11
+0.4% +$2.24K 0.19% 68
2025
Q2 		$548K Buy
2,950
+12
+0.4% +$2.23K 0.17% 79
2025
Q1 		$616K Buy
2,938
+11
+0.4% +$2.14K 0.21% 66
2024
Q4 		$520K Buy
+2,927
New +$538K 0.19% 74

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

CLG LLC's ABBV Position: Q3 2026 in Review

CLG LLC reduced its AbbVie (ABBV) stake by 46% in Q3 2026, selling an estimated $349K and leaving 1,610 shares worth $421K. The position accounts for 0.09% of the portfolio, ranked #99.

CLG LLC first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $748K in Q2 2026. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • CLG LLC held 1,610 shares of AbbVie worth $421K as of Q3 2026.
  • CLG LLC sold 1,361 AbbVie shares in Q3 2026, an estimated $349K.
  • AbbVie made up 0.09% of CLG LLC's portfolio in Q3 2026, its #99 holding.
  • CLG LLC first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • CLG LLC's AbbVie position peaked at $748K in Q2 2026.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on CLG LLC's 13F filing for Q3 2026, filed 13 Oct 2026.